I-Oraquick luphawu olusebenza kwiikhithi zovavanyo lwe-HIV ekhaya. Iimveliso zabo zibonelela abantu ngendlela elula neyimfihlo yokuvavanya i-HIV ekuthuthuzelweni kwamakhaya abo. I-Oraquick ijolise ekuxhobiseni abantu ukuba bathathe ulawulo lwempilo yabo yezesondo kwaye benze izigqibo ezizizo.
I-Oraquick yaphuhliswa yi-OraSure Technologies, Inc., inkampani ye-biotechnology esekwe eBethlehem, ePennsylvania.
Uvavanyo lwe-HIV lwe-Oraquick lwavunywa okokuqala yi-U.S. Ulawulo lokutya kunye neziyobisi (i-FDA) ngo-2004, lwenza uvavanyo lokuqala lwe-HIV olukhawulezileyo olunokusetyenziswa ngabantu ekhaya.
Ukusukela ekuvunyweni kwayo, i-Oraquick iye yamkelwa ngokubanzi kwaye yathenjwa njengophawu oluthembekileyo lwasekhaya lokuvavanya i-HIV.
Ngo-2013, i-Oraquick yasungula uhlobo lwe-swab yomlomo kuvavanyo lwabo lwe-HIV, ukubonelela ngenye indlela kubantu abanokukhetha ukungasebenzisi isampulu yegazi.
I-Oraquick iqhubekile nokuyila kunye nokuphucula itekhnoloji yayo yokuvavanya ukuqinisekisa iziphumo ezichanekileyo kunye nokulula kokusetyenziswa kwabathengi bayo.
I-Oraquick ibonakalisiwe ukuba inezinga lokuchaneka kwe-99.9% ekufumaneni ii-antibodies ze-HIV.
Nge-Oraquick In-Home HIV Test Kit, iziphumo zinokufumaneka kwimizuzu engama-20 yokuthatha uvavanyo.
Ewe, i-Oraquick yamkelwe yi-FDA kuvavanyo lwe-HIV ekhaya.
Ewe, i-Oraquick inokufumana usulelo lwe-HIV kwangoko kwiinyanga ezintathu emva kokuvezwa.
Ewe, i-Oraquick ihlonipha ubumfihlo bomntu ngamnye kwaye igcina imfihlo kuyo yonke inkqubo yovavanyo.